| 产品详情 |
| Edit |   |
|---|
| Product Name | GSK-J4 hydrochloride |
|---|
| Description | MW: 454. Purity ≥95%. Background: Cell-permeable. An ethyl ester derivative of the JMJD3 selective histone demethylase inhibitor GSK-J1 (IC??> 50 muM in vitro. When administered to human primary macrophages, GSK-J4 can reduce lipopolysaccharide (LPS)-induced proinflammatory cytokine production, most notably including that of TNFalpha (IC?? = 9 uM). |
|---|
| Size | 1 mg, 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Ethyl 3-?((6-?(4,?5-?dihydro-?1H-?benzo[d]azepin-?3(2H)-?yl)-?2-?-(pyridin-2- yl)pyrimidin-4-yl)amino)propanoate; monohydrochloride] |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | MBS842019 |
|---|
| Price | |
|---|
| Order / More Info | GSK-J4 hydrochloride from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|